SK Biopharm Moves Into Radiopharma Via $572m Full-Life Deal

Part Of New Modality Focus

 
• By Jung Won Shin
  
growth strategy
SK Biopharm To Announce Radiopharma Plans This Year • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business